(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.38%) $79.29
(-0.37%) $2.18
(-0.18%) $2 318.10
(0.18%) $27.65
(0.22%) $986.80
(0.05%) $0.931
(0.14%) $10.91
(0.02%) $0.800
(-0.01%) $91.73
5 days till quarter result
(bmo 2024-05-14)
Expected move: +/- 9.38%
-3.82% $ 0.920
@ $1.237
Wydano: 14 vas. 2024 @ 16:30
Zwrot: -25.61%
Poprzedni sygnał: vas. 13 - 16:30
Poprzedni sygnał:
Zwrot: -0.24 %
Live Chart Being Loaded With Signals
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight...
Stats | |
---|---|
Dzisiejszy wolumen | 1.09M |
Średni wolumen | 1.44M |
Kapitalizacja rynkowa | 61.51M |
EPS | $0 ( 2024-03-05 ) |
Następna data zysków | ( $0 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.140 |
ATR14 | $0.00400 (0.44%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-15 | Chaubey Alka | Sell | 1 081 | Common Stock |
2024-02-15 | Oldakowski Mark | Sell | 1 229 | Common Stock |
2024-02-15 | Holmlin R. Erik | Sell | 3 073 | Common Stock |
2024-02-15 | Dixon Jonathan V. | Sell | 402 | Common Stock |
2023-09-18 | Oldakowski Mark | Buy | 20 000 | Common Stock |
INSIDER POWER |
---|
83.57 |
Last 99 transactions |
Buy: 20 105 134 | Sell: 833 309 |
Wolumen Korelacja
Bionano Genomics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
MMAT | 0.97 |
AUDC | 0.965 |
OPINL | 0.964 |
ARVL | 0.962 |
ATNF | 0.959 |
HFWA | 0.954 |
WATT | 0.952 |
DISH | 0.95 |
MAGS | 0.95 |
ADN | 0.95 |
10 Najbardziej negatywne korelacje | |
---|---|
BRIVU | -0.974 |
OMAB | -0.945 |
HEWG | -0.945 |
IMOS | -0.941 |
SCHL | -0.935 |
ENER | -0.935 |
SPOK | -0.934 |
SPLK | -0.931 |
APLS | -0.93 |
KYCH | -0.927 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Bionano Genomics Inc Korelacja - Waluta/Towar
Bionano Genomics Inc Finanse
Annual | 2023 |
Przychody: | $36.12M |
Zysk brutto: | $9.57M (26.49 %) |
EPS: | $-6.81 |
FY | 2023 |
Przychody: | $36.12M |
Zysk brutto: | $9.57M (26.49 %) |
EPS: | $-6.81 |
FY | 2022 |
Przychody: | $27.80M |
Zysk brutto: | $5.95M (21.38 %) |
EPS: | $-4.58 |
FY | 2021 |
Przychody: | $17.98M |
Zysk brutto: | $3.87M (21.54 %) |
EPS: | $-0.260 |
Financial Reports:
No articles found.
Bionano Genomics Inc
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej